AzTrials
AzTrials

Feeding Disorder NeonatalPIOMI2020NCT04290338

Effects of PIOMI on Oral Feeding of the Premature Infants

A study testing PIOMI in people with Feeding Disorder Neonatal, run by Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Randomized controlled clinical trial aimed at evaluating the effects of the "Premature infant oral motor intervention" method on the oral feeding skills of the premature infants. Read more about this study

Who is it for?
Ages 25 to 33 weeks
Conditions the study is for
Feeding Disorder Neonatal
What is being tested?
PIOMI
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
No sites listed yet
Study dates
Mar 2020to Sep 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 25 to 33 weeks
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • gestational age at birth between 25-33 weeks;
  • clinical stability;
  • possible presence of nasogastric or oro-gastric tube;
  • non-invasive respiratory support (oxygen, high flows)

Who cannot join

  • gestational age <25 weeks or> 33 weeks
  • absence of clinical stability
  • invasive respiratory support (CPAP)
  • previous surgical interventions
  • ongoing infections
  • congenital and / or chromosomal diseases
  • brain, metabolic, cardiac, gastrointestinal diseases
  • presence of bronchopulmonary dysplasia

Trial locations and contacts

No sites are listed yet.

Odoardo Picciolini, physiatrist contact

0255034354

odoardo.picciolini@policlinico.mi.it

Matteo Porro, physiatrist contact

0255034353

matteo.porro@policlinico.mi.it

About this study

Official title: Effects of the Premature Infant Oral Motor Intervention on the Oral Feeding Skills of the Premature Infants: A Randomized Controlled Trial

Randomized controlled clinical trial aimed at evaluating the effects of the "Premature infant oral motor intervention" method on the oral feeding skills of the premature infants.

Read the detailed description

Numerous evidences emerge from the literature review on the usefulness of the PIOMI method to improve food skills in the premature infant. The goal of this study is to evaluate the effects of the PIOMI method by adding the gustatory stimulation to the original protocol.

Being tested
PIOMI

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • PIOMIOther

    Intraoral and extraoral stimulation.

Study groups in NCT04290338
Study groupRoleWhat they receive
PIOMI GroupExperimentalPatients in this group will receive the intraoral and extraoral stimulations provided by the PIOMI protocol. These stimulations will last 5 minutes and will be performed once a day for 7 consecutive days for each patient.
Receives: Other: PIOMI
Control GroupNo interventionPatients in this group will receive classic care.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Mean volume

    Mean volume of oral intake

    Measured: 7 days

Secondary outcomes (4)
  1. feeding efficiency

    oral intake at day one and at day three

    Measured: 3 days

  2. achievement of full oral feeding

    PMA on reaching full oral feeding

    Measured: 6 moths

  3. hospital stay time

    days spending to the hospital

    Measured: 6 months

  4. transition time

    transition times from the tube to full oral feeding

    Measured: 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Feb 2020
  2. Study startMar 2020 (estimated)
  3. Primary completionAug 2020 (estimated)
  4. Study completionSep 2020 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
RCT characterized by the comparison between two groups (treated / untreated)
Masking
Single blind
Who is masked
Participant
Enrolment
40 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04290338
Sponsor's protocol ID
PIOMI2020Policlinico
Acronym
PIOMI2020
Status last verified
Feb 2020
First submitted
24 Feb 2020
Last updated
28 Feb 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: all collected IPD may result in a publication.

Questions about this trial

What is this clinical trial studying?

A study testing PIOMI in people with Feeding Disorder Neonatal, run by Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 28 Feb 2020. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Odoardo Picciolini, physiatrist (0255034354, odoardo.picciolini@policlinico.mi.it), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Mean volume (time frame: 7 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Feb 2020; AzTrials last refreshed its copy on 8 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in